UK markets closed

Can-Fite BioPharma Ltd. (CANF)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
2.4700-0.0866 (-3.39%)
At close: 03:55PM EDT
2.5800 +0.11 (+4.45%)
After hours: 05:41PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-11,272
-7,634
-10,173
-12,615
-14,443
-
Depreciation & amortisation
15
15
14
14
12
-
Stock-based compensation
261
261
263
466
355
-
Change in working capital
-943
-943
-1,301
2,430
1,992
-
Accounts receivable
-
-
-
-
2,726
270
Accounts payable
-469
-469
-58
393
-1,595
-
Other working capital
-8,442
-8,442
-10,810
-9,869
-12,089
-
Other non-cash items
-222
-222
113
-46
23
-
Net cash provided by operating activities
-8,440
-8,440
-10,801
-9,858
-12,063
-
Cash flows from investing activities
Investments in property, plant and equipment
-2
-2
-9
-11
-26
-
Purchases of investments
-
-
-
-14,500
0
0
Other investing activities
-
-
-
-
-
-250
Net cash used for investing activities
498
498
9,502
-14,511
-26
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
-34
Common stock issued
9,144
9,144
0
20,457
17,683
-
Net cash used provided by (used for) financing activities
9,144
9,144
0
20,457
17,683
-
Net change in cash
1,300
1,300
-1,412
-3,878
5,571
-
Cash at beginning of period
2,978
2,978
4,390
8,268
2,697
-
Cash at end of period
4,278
4,278
2,978
4,390
8,268
-
Free cash flow
Operating cash flow
-8,440
-8,440
-10,801
-9,858
-12,063
-
Capital expenditure
-2
-2
-9
-11
-26
-
Free cash flow
-8,442
-8,442
-10,810
-9,869
-12,089
-